n research and clinical trials in lymphoma, multiple myeloma, blood and marrow stem cell transplantation and leukemia. Regional Cancer Care Associates physicians at John Theurer Cancer Center are lead or senior author in 15 studies, including Andre Goy, M.D.; Michele Donato, M.D., collection facility medical director, blood and marrow transplantation; Tatyana Feldman, M.D., lymphoma oncologist; Stuart Goldberg, M.D., chief, leukemia; Robert Korngold, Ph.D., chief, research; Anthony Mato, M.D., director of our chronic lymphocytic leukemia program; Scott Rowley, M.D., chief, blood and marrow transplantation; David Siegel, M.D., Ph.D., chief, multiple myeloma.
"We are committed to contributing to blood cancer research through our own investigator-initiated research and collaborating with other institutions," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., chief innovation officer, professor and vice president of cancer services, John Theurer Cancer Center and President of Regional Cancer Care Associates. "I want to thank our physicians and research staff for their dedication, as well as all of the patients who participate in our studies."
For those attending the ASH annual meeting, visit John Theurer Cancer Center at Booth 3413. The following are abstracts and presentations at ASH annual meeting from John Theurer Cancer Center. For ongoing updates and complete list of abstracts, please visit jtcancercenter.org/ash2012.
John Theurer Cancer Center 2012 ASH Abstracts:
Page: 1 2 3 4 5 6 7 Related medicine news :1
- 59 A Phase I Study of DCDT2980S, an Antibody-Drug Conjugate (ADC) Targeting CD22, in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL), Andre Goy, MD, Oral Session: Dec. 12, 2012 Time: 1:00 PM
- 471 Pre-Emptive T-Rapa Cell DLI for Therapy of High-Risk Lymphoma After Low-Intensity Allogeneic HCT, Scott Rowley, M.D., Oral session: Dec. 10, 2012 Time: 11:00AM
. John Theurer Cancer Center researchers shed light on new multiple myeloma therapy2
. Experts from John Theurer Cancer Center to participate in the AAMDSIF Patient and Family Conference3
. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium4
. UT MD Anderson, GlaxoSmithKline to collaborate on new approach to cancer immune therapy5
. Protein tied to cancer-drug resistance in mice6
. Study compares standard against newer treatment in women whose breast cancer has spread7
. Existing drugs may help more breast cancer patients8
. Protein tied to cancer drug resistance in mice9
. The effect of treating institution on outcomes in head and neck cancer10
. New Online Resource Acts As Powerful Tool in the Battle against Cancer11
. For Aggressive Breast Cancer, Chemo May Work Better in the Young